In the TCGA–BLCA cohort, KDM6A, FGFR3, STAG2, OBSCN, BIRC, ADGRV1, DST, ABCA13, USP34, and TENM3 had more frequent mutation in samples with low PRKG1 expression. Here, DST is linked to bladder transitional cell carcinoma.